Nurtricology Artemisinin matches control Performed by Xiaolong Meng and Jie Zhong at The Center for Improvement of Human Functioning International, Inc., Wichita, Kansas, 08/20/2002 Objective: Test the cytotoxicity for Nutricology and Sigma-Aldrich artemisinin on two transformed cell lines (HL-60 and K562). Method: Incubate cells with artemisinin at four concentrations (1, 10, 50, 200 µM). Artemisinin concentration in control samples is 0 (samples with no artemisinin added). Read plate at 0, 1, 2, 6, 24 and 96 hours and calculate the cell inhibitions. Results: Before 24 hours, the cell inhibitions had poor dose response. The longer the incubation, the higher the cell inhibition. The highest cell inhibition was at 96 hours at the artemisinin concentration 200 µM. Compare to control, at 96 hours and 200 µM, ARG artemisinin reached the inhibition of 20% and 59%, while Sigma Artemisinin reached 17% and 51% for HL-60 and K562 lymphoma cell lines, respectively. Summary: Both Artemisinins showed higher sensitivity to K562 cells than to HL-60 cells. Allergy Research Group artemisinin and Sigma-Aldrich artemisinin were similar in their cytotoxicity activities. "I am extremely satisfied with the superb quality of your product and the excellent clinical results we witness daily from its use."
- Christopher Deatherage, N.D., Brush Creek Naturopathic Health Center, Drury, MO "I have been very impressed by the efforts of ARG to perform both purity analysis and activity analysis on its artemisinin. For me, it was not even necessary, since I had already observed the awesome clinical efficacy of the product in patient after patient. I am grateful that this product is available and at a most reasonable price."
- Robert Jay Rowen, M.D., Editor-in-Chief, Second Opinion |
